Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Wirecard AG

Start price
Target price
Perf. (%)
€0.87
€1.15
-2.712%

Very high cyclical dependencies
Risky Investment
Verbio Ver.bioenergie

Start price
Target price
Perf. (%)
€16.98
€22.00
-0.942%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Medigene AG

Start price
Target price
Perf. (%)
€4.63
€6.00
-0.649%

Could be worthwhile Investment >10% per year
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.20
€12.00
-3.571%

Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€6.70
€8.00
1.493%

Could be worthwhile Investment >10% per year
Cutera Inc.

Start price
Target price
Perf. (%)
€16.40
€18.00
1.220%

Could be worthwhile Investment >10% per year
CHF Solutions Inc

Start price
Target price
Perf. (%)
€0.19
€0.000
-

Could be very worthwhile Investment >20% year
GoldMining Inc

Start price
Target price
Perf. (%)
€2.25
€3.00
-1.559%

Could be worthwhile Investment >10% per year
Kelly Services Inc. A

Start price
Target price
Perf. (%)
€14.00
-
0.714%

Risky Investment
Paragon AG

Start price
Target price
Perf. (%)
€9.89
-
-4.955%

Capable Management
Revenue growth >5% per year expected
Samsung Sdi GDR

Start price
Target price
Perf. (%)
€77.40
-
4.910%

Future proof or reliable business model
Market Leader or Top 3
Innovative
Well known brand
Curevac N.V.

Start price
Target price
Perf. (%)
€48.40
-
-7.387%

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Panasonic Corp.

Start price
Target price
Perf. (%)
€7.65
-
0.941%

Some uniques
Future proof or reliable business model
Innovative
Differentiated customer and product portfolio
Jinkosolar ADR

Start price
Target price
Perf. (%)
€17.58
-
13.766%

Sustainability is very important
Innovative
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€135.80
€150.00
3.976%

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
Borussia Dortmund

Start price
Target price
Perf. (%)
€5.69
-
7.381%

Top 10 in its market
Capable Management
Some uniques
Revenue decline/stagnation expected
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.28
-
57.005%

Could be very worthwhile Investment >20% year
Wirecard AG

Start price
Target price
Perf. (%)
€1.15
-
-26.078%

Risky Investment
LPKF Laser & Electronics AG

Start price
Target price
Perf. (%)
€21.00
€25.00
7.143%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Zooplus AG

Start price
Target price
Perf. (%)
€140.40
€141.00
-3.989%

Probably not worthwhile Investment
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€126.00
€140.00
12.064%

Medium risks for its business
Curevac N.V.

Start price
Target price
Perf. (%)
€52.00
-
-13.808%

Curevac N.V.

Start price
Target price
Perf. (%)
€52.00
-
-13.808%

Could be worthwhile Investment >10% per year
Groupon Inc. A

Start price
Target price
Perf. (%)
€1.22
-
-

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€7.11
-
-19.423%

Small cyclical dependencies
Probably not worthwhile Investment
Higher risks for its business
negative Cash Flow expected